🎉 M&A multiples are live!
Check it out!

Roche Valuation Multiples

Discover revenue and EBITDA valuation multiples for Roche and similar public comparables like Pharming, Armata Pharmaceuticals, and Galapagos.

Roche Overview

About Roche

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.


Founded

1896

HQ

Switzerland
Employees

103.2K+

Website

roche.com

Financials

LTM Revenue $74.1B

LTM EBITDA $29.2B

EV

$274B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Roche Financials

Roche has a last 12-month revenue of $74.1B and a last 12-month EBITDA of $29.2B.

In the most recent fiscal year, Roche achieved revenue of $74.9B and an EBITDA of $20.0B.

Roche expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Roche valuation multiples based on analyst estimates

Roche P&L

LTM NTM FY 2025 FY 2026 FY 2027
Revenue $74.1B XXX XXX XXX XXX
Gross Profit $55.2B XXX XXX XXX XXX
Gross Margin 74% XXX XXX XXX XXX
EBITDA $29.2B XXX XXX XXX XXX
EBITDA Margin 39% XXX XXX XXX XXX
EBIT $25.6B XXX XXX XXX XXX
EBIT Margin 35% XXX XXX XXX XXX
Net Profit $13.7B XXX XXX XXX XXX
Net Margin 18% XXX XXX XXX XXX
Net Debt $33.2B XXX XXX XXX XXX

Financial data powered by Morningstar, Inc.

Roche Stock Performance

As of May 30, 2025, Roche's stock price is CHF 262 (or $315).

Roche has current market cap of CHF 209B (or $251B), and EV of CHF 228B (or $274B).

See Roche trading valuation data

Roche Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$274B $251B XXX XXX XXX XXX $23.23

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Roche Valuation Multiples

As of May 30, 2025, Roche has market cap of $251B and EV of $274B.

Roche's trades at 3.7x EV/LTM Revenue multiple, and 9.4x EV/LTM EBITDA.

Equity research analysts estimate Roche's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Roche has a P/E ratio of 18.3x.

See valuation multiples for Roche and 10K+ public comps

Roche Financial Valuation Multiples

LTM NTM FY 2025 FY 2026 FY 2027
Market cap (current) $251B XXX XXX XXX XXX
EV (current) $274B XXX XXX XXX XXX
EV/Revenue 3.7x XXX XXX XXX XXX
EV/EBITDA 9.4x XXX XXX XXX XXX
EV/EBIT 10.7x XXX XXX XXX XXX
EV/Gross Profit 5.0x XXX XXX XXX XXX
P/E 18.3x XXX XXX XXX XXX
EV/FCF 14.8x XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Roche Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Roche Margins & Growth Rates

Roche's last 12 month revenue growth is 5%

Roche's revenue per employee for the last 12 months averaged $0.7M, while opex per employee averaged $0.4M for the same period.

Roche's rule of 40 is 35% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Roche's rule of X is 51% (another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Roche and other 10K+ public comps

Roche Operational Valuation Multiples

LTM NTM FY 2025 FY 2026 FY 2027
Revenue Growth 5% XXX XXX XXX XXX
EBITDA Margin 39% XXX XXX XXX XXX
EBITDA Growth 5% XXX XXX XXX XXX
Rule of 40 35% XXX XXX XXX XXX
Bessemer Rule of X 51% XXX XXX XXX XXX
Revenue per Employee $0.7M XXX XXX XXX XXX
Opex per Employee $0.4M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 25% XXX XXX XXX XXX
Opex to Revenue 52% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Roche Public Comps

See public comps and valuation multiples for Biopharmaceuticals and Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
Armata Pharmaceuticals XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Roche M&A and Investment Activity

Roche acquired  XXX companies to date.

Last acquisition by Roche was  XXXXXXXX, XXXXX XXXXX XXXXXX . Roche acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Roche

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About Roche

When was Roche founded? Roche was founded in 1896.
Where is Roche headquartered? Roche is headquartered in Switzerland.
How many employees does Roche have? As of today, Roche has 103.2K+ employees.
Is Roche publicy listed? Yes, Roche is a public company listed on SWX.
What is the stock symbol of Roche? Roche trades under ROG ticker.
When did Roche go public? Roche went public in 2001.
Who are competitors of Roche? Similar companies to Roche include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of Roche? Roche's current market cap is $251B
What is the current revenue of Roche? Roche's last 12 months revenue is $74.1B.
What is the current revenue growth of Roche? Roche revenue growth (NTM/LTM) is 5%.
What is the current EV/Revenue multiple of Roche? Current revenue multiple of Roche is 3.7x.
Is Roche profitable? Yes, Roche is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Roche? Roche's last 12 months EBITDA is $29.2B.
What is Roche's EBITDA margin? Roche's last 12 months EBITDA margin is 39%.
What is the current EV/EBITDA multiple of Roche? Current EBITDA multiple of Roche is 9.4x.
What is the current FCF of Roche? Roche's last 12 months FCF is $18.5B.
What is Roche's FCF margin? Roche's last 12 months FCF margin is 25%.
What is the current EV/FCF multiple of Roche? Current FCF multiple of Roche is 14.8x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.